Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Safe Pseudovirus-based Assay for Neutralization Antibodies against Influenza A(H7N9) Virus
  • Published Date:
    Oct 2013
  • Source:
    Emerg Infect Dis. 19(10):1685-1687.
Filetype[PDF-369.50 KB]


Details:
No Related Documents.
You May Also Like:
  1. Recombinant virus-like particles elicit protective immunity against avian influenza A(H7N9) virus infection in ferrets
    Personal Author:
    Liu, Ye V.; Massare, Michael J.; Pearce, Melissa B.; Sun, Xiangjie; Belser, Jessica A.; Maines, Taronna R.; Creager, Hannah M.; Glenn, Gregory M.; Pushko, Peter; Smith, Gale E.; Tumpey, Terrence M.;
    Published Date:
    Mar 13 2015
    Source:
    Vaccine. 33(18):2152-2158.
    Description:
    In March 2013, diagnosis of the first reported case of human infection with a novel avian-origin influenza A(H7N9) virus occurred in eastern China. Most human cases have resulted in severe respiratory illness and, in some instances, death. Currently ...
    File Type:
    Filetype[PDF - 489.39 KB]
  2. A Neutralizing Monoclonal Antibody Targeting the Acid-Sensitive Region in Chikungunya Virus E2 Protects from Disease
    Personal Author:
    Selvarajah, Suganya; Sexton, Nicole R.; Kahle, Kristen M.; Fong, Rachel H.; Mattia, Kimberly-Anne; Gardner, Joy; Lu, Kai; Liss, Nathan M.; Salvador, Beatriz; Tucker, David F.; Barnes, Trevor; Mabila, Manu; Zhou, Xiangdong; Rossini, Giada; Rucker, Joseph B.; Sanders, David Avram; Suhrbier, Andreas; Sambri, Vittorio; Michault, Alain; Muench, Marcus O.; Doranz, Benjamin J.; Simmons, Graham;
    Published Date:
    Sep 12 2013
    Source:
    PLoS Negl Trop Dis. 2013; 7(9).
    Description:
    The mosquito-borne alphavirus, chikungunya virus (CHIKV), has recently reemerged, producing the largest epidemic ever recorded for this virus, with up to 6.5 million cases of acute and chronic rheumatic disease. There are currently no licensed vaccin...
    File Type:
    Filetype[PDF - 1.52 MB]
  3. Human Monoclonal Antibody 81.39a Effectively Neutralizes Emerging Influenza A Viruses of Group 1 and 2 Hemagglutinins
    Personal Author:
    Marjuki, Henju; Mishin, Vasiliy P.; Chai, Ning; Tan, Man-Wah; Newton, Elizabeth M.; Tegeris, John; Erlandson, Karl; Willis, Melissa; Jones, Joyce; Davis, Todd; Stevens, James; Gubareva, Larisa V.;
    Published Date:
    November 14 2016
    Source:
    J Virol. 2016; 90(23):10446-10458
    Description:
    The pandemic threat posed by emerging zoonotic influenza A viruses necessitates development of antiviral agents effective against various antigenic subtypes. Human monoclonal antibody (hMAb) targeting the hemagglutinin (HA) stalk offers a promising a...
    File Type:
    Filetype[PDF - 3.28 MB]
  4. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies
    Personal Author:
    Kamal, Ram P.; Blanchfield, Kristy; Belser, Jessica A.; Music, Nedzad; Tzeng, Wen-Pin; Holiday, Crystal; Burroughs, Ashley; Sun, Xiangjie; Maines, Taronna R.; Levine, Min Z.; York, Ian A.;
    Published Date:
    Sep 27 2017
    Source:
    J Virol. 2017; 91(20).
    Description:
    Avian influenza viruses of the H7 hemagglutinin (HA) subtype present a significant public health threat, as evidenced by the ongoing outbreak of human A(H7N9) infections in China. When evaluated by hemagglutination inhibition (HI) and microneutraliza...
    File Type:
    Filetype[PDF - 2.85 MB]
  5. Neutralizing Antibody Response and SARS Severity
    Personal Author:
    Ho, Mei-Shang; Chen, Wei-Ju; Chen, Hour-Young; Lin, Szu-Fong; Wang, Min-Chin; Di, Jiali; Lu, Yen-Ta; Liu, Ching-Lung; Chang, Shan-Chwen; Chao, Chung-Liang; King, Chwan-Chuen; Chiou, Jeng-Min; Su, Ih-Jen; Yang, Jyh-Yuan;
    Published Date:
    Nov 2005
    Source:
    Emerg Infect Dis. 11(11):1730-1737.
    Description:
    Using the Taiwan nationwide laboratory-confirmed severe acute respiratory syndrome (SARS) database, we analyzed neutralizing antibody in relation to clinical outcomes. With a linear mixed model, neutralizing antibody titer was shown to peak between w...
    File Type:
    Filetype[PDF - 350.84 KB]